# LEVOLEUCOVORIN CALCIUM
> **ANDA210892** · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2018-09-14
## Drug
- **FDA Application Number:** ANDA210892
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LEVOLEUCOVORIN CALCIUM
- **Generic name:** LEVOLEUCOVORIN
- **Active ingredients:** LEVOLEUCOVORIN CALCIUM
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** GLAND
- **Manufacturer:** Gland Pharma Limited
- **First approval:** 2018-09-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210892)
---
*AI Analytics · CC0 1.0*